At the peak of the Coronavirus pandemic, like many manufaturers in the UK, LMK Thermosafe sought to find ways to use its skills to assist front-line NHS services.

The company writes:

Depending on how you work with your inbox, you could end up with Outlook marking your email message as read, while you really only flicked through the list using your up and down arrows, having a quick peak at the text in the Reading Pane.

Busy Bee Recruitment writes:

This year we have decided to focus on men’s mental health as the COVID-19 pandemic means that many of us are staying at home and this can have a negative effect on mental health.

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, presented positive results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247, at the

With today’s agreement, the IVA aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the initiative. The IVA is committed to providing equitable access to all participating countries across Europe.

Looking for something specific?

At the peak of the Coronavirus pandemic, like many manufaturers in the UK, LMK Thermosafe sought to find ways to use its skills to assist front-line NHS services.

The company writes:

Depending on how you work with your inbox, you could end up with Outlook marking your email message as read, while you really only flicked through the list using your up and down arrows, having a quick peak at the text in the Reading Pane.

Busy Bee Recruitment writes:

This year we have decided to focus on men’s mental health as the COVID-19 pandemic means that many of us are staying at home and this can have a negative effect on mental health.

Arecor Limited, the biopharmaceutical company advancing today’s therapies to enable healthier lives, presented positive results for the Phase I clinical trial of its ultra-rapid acting insulin product candidate, AT247, at the

With today’s agreement, the IVA aims to accelerate the supply of the vaccine and to make it available to other European countries that wish to participate in the initiative. The IVA is committed to providing equitable access to all participating countries across Europe.